Resveratrol Ameliorates Motor Neuron Degeneration and Improves Survival in SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis

Abstract EN

Resveratrol has recently been used as a supplemental treatment for several neurological and nonneurological diseases.

It is not known whether resveratrol has neuroprotective effect on amyotrophic lateral sclerosis (ALS).

To assess the effect of resveratrol on the disease, we tested this agent on an ALS model of SOD1G93A transgenic mouse.

Rotarod measurement was performed to measure the motor function of the ALS mice.

Nissl staining and SMI-32 immunofluorescent staining were used to determine motor neurons survival in the spinal cord of the ALS mice.

Hematoxylin-eosin (H&E), succinic dehydrogenase (SDH), and cytochrome oxidase (COX) staining were applied to pathologically analyze the skeletal muscles of the ALS mice.

We found that resveratrol treatment significantly delayed the disease onset and prolonged the lifespan of the ALS mice.

Furthermore, resveratrol treatment attenuated motor neuron loss, relieved muscle atrophy, and improved mitochondrial function of muscle fibers in the ALS mice.

In addition, we demonstrated that resveratrol exerted these neuroprotective effects mainly through increasing the expression of Sirt1, consequently suppressing oxidative stress and downregulating p53 and its related apoptotic pathway.

Collectively, our findings suggest that resveratrol might provide a promising therapeutic intervention for ALS.